FZD7 is a Wnt co-receptor, and its expression in various cancers is associated with aberrant activation of the Wnt pathway promoting EMT, and thus metastatic development in prostate and pancreatic cancers (Wang L. et al., 2022; Zhang and Xu, 2022). The gene discussed is FZD7; the disease is cancer.